Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers

Details for Australian Patent Application No. 2002301149 (hide)

Owner Viventia Biotech Inc.

Inventors Dan, Michael D.

Agent Davies Collison Cave

Pub. Number AU-A-2002301149

Parent 79273

Filing date 23 September 2002

Wipo publication date 27 February 2003

International Classifications

C07H 021/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002301149

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301150-Method and apparatus for heat disinfestation

2002301148-A cultivator chain